STAT+: Most-favored nations policy makes drugmakers rethink launches abroad

🇺🇸 STAT News Health (US) —
STAT+: Most-favored nations policy makes drugmakers rethink launches abroad

AI Summary

Drugmakers are reportedly considering ways to protect U.S. sales from the Trump administration's most-favored-nations drug pricing policy. The policy is prompting companies to rethink how and where they launch medicines abroad.

Drug companies seem to be looking for workarounds to protect their U.S. sales against Trump's "most-favored nations" policy:

World Politics Markets Health drug pricing most-favored-nations policy pharmaceuticals U.S. sales medicine launches trade policy

Read original source →